News

India's anti-obesity drug market shows significant growth. It has increased fourfold in five years. Lifestyle diseases and ...
India's anti-obesity drug market has surged, growing over fourfold in five years, reaching Rs 576 crore by March 2025.
India's anti-obesity drug market has surged, growing over fourfold in five years, reaching ₹576 crore by March 2025, driven ...
India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...
One popular and affordable supplement that has shown some promise in helping with weight loss is berberine. In fact, some ...
Who knew weight loss involved so much math? Counting calories can be a useful tool to help you lose weight and keep it off.
The 50 mg oral semaglutide pill achieved a 15.1% weight loss in the phase 3 OASIS study involving patients who were overweight or obese, but who did not have diabetes, with the results ...
Novo is also developing semaglutide in a patient-friendly pill form. Launched in 2015, Trulicity is making an impact in the competitive GLP-1 market, much of its appeal derived from it more ...
"I've said this before, but as more data comes in I become more convinced that we may look back on these drugs as the ...
Because these pills can have serious side effects and ... Currently, only liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are approved for weight loss, though some other ...
Berberine is a powder made from different plants. It has many benefits, including improving blood sugar levels, reducing ...